Search

everythinglearnresearchcommunity

for

Search:↓

High androgen levels and genetic factors likely cause Becker's nevus and related symptoms.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Finasteride reduces hirsutism effectively with fewer side effects but is a second-choice treatment due to safety concerns.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Spironolactone successfully treated hair loss in a 9-year-old girl.

Women with hyperandrogenic amenorrhea have similar bone density to healthy women but lower than androgenized women without amenorrhea, and high DHEAS levels might affect bone density.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Most cases of excessive hair growth in women are caused by polycystic ovarian syndrome and are linked to higher free testosterone levels.

Spironolactone may help reduce hair loss in androgenic alopecia.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Women with PCOS in North China often have hirsutism and acne, with hirsutism linked to metabolic issues.

Men with advanced liver disease and high oestrone and low testosterone levels have worse health outcomes.

Obese women had more testosterone and less acne, but similar hair growth compared to non-obese women.

Spironolactone can reduce hair growth and testosterone in hirsutism, but is less effective than combined treatments.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.

Balding men have higher heart disease risk.

Irregular menstrual cycles in teenagers are linked to a higher risk of polycystic ovary syndrome and metabolic syndrome.

Men with male-pattern baldness have higher levels of certain testosterone metabolites and may have more active androgen metabolism.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

The document explains that hirsutism, often caused by hormonal issues, can be managed with treatment to improve both physical appearance and mental health.

A small number of premenopausal female blood donors had high prolactin levels, often due to stress, and retesting is recommended to prevent misdiagnosis.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

Hair loss drugs like finasteride may cause lasting sexual and mood side effects, and more research is needed to understand these risks.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

Testosterone and dihydrotestosterone have similar effects on body composition and metabolic health in men.

Normal-range ALT levels can indicate metabolic and hormonal imbalances in young women.

This text talks about how to treat hair loss in women. It suggests different options and stresses the importance of support.

AGA patients have higher heart disease risk.

Metformin helps improve symptoms and reproductive outcomes in people with polycystic ovary syndrome.